
Join to View Full Profile
10506A Montgomery RdMontgomery, OH 45242
Phone+1 513-853-1300
Fax+1 513-451-4118
Dr. Girnius is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Boston University Medical CenterResidency, Internal Medicine, 2006 - 2009
- University of Cincinnati College of MedicineClass of 2006
- University of Michigan-Ann ArborBS, Cellular and Molecular Biology, 1998 - 2001
Certifications & Licensure
- OH State Medical License 2013 - 2027
- MA State Medical License 2008 - 2013
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Travel Award Amyloid Foundation, 2010
- Travel Award ASH, 2007
- Simon Pendleton Kramer Research Award 2006
Publications & Presentations
PubMed
- 48 citationsAutologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A center for international blood and marrow transplant research a...Anuj Mahindra, Parameswaran Hari, Raphael Fraser, Mingwei Fei, Jiaxing Huang
Bone Marrow Transplantation. 2017-09-18 - 8 citationsA Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transpl...Saulius K. Girnius, Saem Lee, Suman Kambhampati, Michal G. Rose, Abid Mohiuddin
British Journal of Haematology. 2015-04-01 - 40 citationsSafety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.Saulius Girnius, David C. Seldin, Hans K. Meier-Ewert, John Mark Sloan, Karen Quillen
Bone Marrow Transplantation. 2014-03-01
Journal Articles
- Safety and Efficacy of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients with AL Amyloidosis and Cardiac InvolvementGirnius S, Seldin DS, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V, Bone Marrow Transplant, 12/9/2013
- Overview of Systemic and Localized AmyloidosisGirnius S, Reviews in Healthcare, 10/2013
- New Hematologic Response Criteria Predict Survival In Patients With Immunoglobulin Light Chain Amyloidosis Treated With High-Dose Melphalan And Autologous Stem Cell Tr...Girnius S, Seldin DC, Cibeira, M, and Sanchorawala V, J Clin Oncol, 7/1/2013
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: